Kyle M. LaPak
Impact in
-
- Cancer-related Molecular Pathways
Papers in
-
- Genomics, phytochemicals, and oxidative stress 4
- Ubiquitin and proteasome pathways 2
- Histone Deacetylase Inhibitors Research 2
- Oncology 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Christin E. Burd (3 shared papers)Rebecca C. Hennessey (1 shared paper)Xiangnan Guan (2 shared papers)Reena Shakya (1 shared paper)Christina Y. Yu (1 shared paper)Jianying Zhang (1 shared paper)Michael B. Major (6 shared papers)Dennis Goldfarb (5 shared papers)
- Journals
- Nature Communications (2 papers)Journal of Biological Chemistry (2 papers)Molecular Cancer Research (2 papers)Journal of Cell Science (1 paper)Oncotarget (1 paper)
- Partner nations
- United States
In The Last Decade
Kyle M. LaPak
11 papers receiving 358 citations
Peers
Comparison fields: 5 of 70
- Aging 8
- Oncology 96
- Physiology 90
- Cancer Research 49
- Geriatrics and Gerontology 9
Countries citing papers authored by Kyle M. LaPak
This map shows the geographic impact of Kyle M. LaPak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyle M. LaPak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyle M. LaPak more than expected).
Fields of papers citing papers by Kyle M. LaPak
This network shows the impact of papers produced by Kyle M. LaPak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyle M. LaPak. The network helps show where Kyle M. LaPak may publish in the future.
Co-authors
The 25 scholars most cited alongside Kyle M. LaPak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 219 | |
| 2 | 2016 | 83 | |
| 3 | 2020 | 20 | |
| 4 | 2023 | 15 | |
| 5 | 2022 | 7 | |
| 6 | 2023 | 6 | |
| 7 | 2024 | 6 | |
| 8 | 2018 | 3 | |
| 9 | 2025 | 2 | |
| 10 | 2025 | 1 | |
| 11 | 2021 | 1 |
About Kyle M. LaPak
Kyle M. LaPak is a scholar working on Molecular Biology, Oncology, Infectious Diseases, Genetics and Pulmonary and Respiratory Medicine, having authored 11 papers that have together received 363 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (4 papers), Ubiquitin and proteasome pathways (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Cancer-related Molecular Pathways (2 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (1 paper), Eicosanoids and Hypertension Pharmacology (1 paper), Bioactive Compounds and Antitumor Agents (1 paper) and Telomeres, Telomerase, and Senescence (1 paper). The work is most often cited by research in Aging (8 citations), Oncology (96 citations), Physiology (90 citations), Cancer Research (49 citations) and Geriatrics and Gerontology (9 citations). Kyle M. LaPak has collaborated with scholars based in United States. Frequent co-authors include Christin E. Burd, Rebecca C. Hennessey, Xiangnan Guan, Reena Shakya, Christina Y. Yu, Jianying Zhang, Michael B. Major, Dennis Goldfarb, Brittany M. Bowman and Travis P. Schrank. Their work appears in journals such as Nature Communications, Journal of Biological Chemistry, Molecular Cancer Research, Journal of Cell Science and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.